More evidence supports vismodegib therapy for advanced periocular basal cell carcinoma

This retrospective case series evaluated the effectiveness of the hedgehog pathway inhibitor vismodegib for advanced periocular basal cell carcinoma (BCC).
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553